Cudis vs Immunefi — how do they compare? Cudis trades at Rp87.55 (market cap Rp21,36M, Rp77,87M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Immunefi is the larger of the two by market cap, and Cudis's circulating supply is 247,5M / 1B CUDIS (25%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Cudis for 11 Days and Immunefi for 5 Days on average.
| CUDIS | IMU | |
|---|---|---|
Market Cap | Rp21,36M | Rp27,03M |
Volume (24h) | Rp77,87M | Rp39,91M |
Circulating Supply | 247,5M / 1B CUDIS (25%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 11 Days | 5 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →